FiftyBidsGovernment contracts and grants, in one plain-English search.

Back to search

Forecast

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

The DISCOVERY of Risk Factors for Type 2 Diabetes in Youth Study is a multi-center longitudinal consortium conducted across 19 clinical sites to identify risk factors and biological mechanisms driving progression to youth-onset type 2 diabetes.

FromNational Institutes of Health
Who can applyothers (see eligibility notes)
Eligibility notesThis is a Single Source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information.
How muchabout 1 award; $35 million total
DeadlineWed, Mar 10, 2027 (estimated) (138 days left)
CategoryHealth
TypeCooperative agreement
Opportunity #RFA-DK-28-115
Assistance listing93.847
PostedTue, Aug 4, 2026

Heads-up: Forecast: not open yet. Dates and amounts are the agency's estimates.

Open the official posting

From the notice

The DISCOVERY of Risk Factors for Type 2 Diabetes in Youth Study is a multi-center longitudinal consortium conducted across 19 clinical sites to identify risk factors and biological mechanisms driving progression to youth-onset type 2 diabetes. The study is actively recruiting and following early pubertal youth at high risk for the disease with longitudinal follow-up currently underway. The current Biostatistics Research Center (BRC) serves as the consortium's central coordinating center, managing protocol implementation, data management, quality assurance, statistical design and analysis, and inter-site and consortium-wide coordination. The BRC has established the robust infrastructure and standardized processes required to support the study and preserve the integrity of the longitudinal dataset. The purpose of this single-source solicitation is to support completion of the scientific objectives of the ongoing DISCOVERY clinical consortium.

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.